Netarsudil 0.02% ophthalmic solution
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Netarsudil 0.02% ophthalmic solution, covering 2023-02-27 to 2023-02-27. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy and Safety Study of Netarsudil 0.02% Ophthalmic Solution Compared to Ripasudil Hydrochloride Hydrate 0.4% Ophthalmic Solution in Japanese Subjects With Primary Open Angle Glaucoma or Ocular Hypertension [Phase 3]